Stocks
Athira Pharma, Inc.ATHA
NASDAQHealthcareBiotechnology$6.75-6.12%
Focused on therapies for neurodegenerative diseases, the company develops small‑molecule drugs aimed at conditions such as Alzheimer’s and Parkinson’s disease dementia. Its pipeline is built around compounds designed to stimulate neurotrophic signaling pathways to support neuron survival and functio...
Market Cap: $26.6M52W Range: $2.20 – $8.36
This page tracks all publicly disclosed congressional trades in Athira Pharma, Inc. (ATHA), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 2 purchases and 1 sale. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
3
Unique Politicians
1
Buys
2
Sells
1
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-12-12 | Christopher L. Jacobs | buy | $1K – $15K |
| 2022-11-08 | Christopher L. Jacobs | sell | $1K – $15K |